Pfizer (PFE) EBT Margin (QoQ) (2009 - 2026)
Pfizer (PFE) EBT Margin (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.40 Bn | 624.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.79 Bn | 456.22 Bn | 12.70 Bn |
| 3 | Merck | 369.55 Bn | 362.41 Bn | 12.21 Bn |
| 4 | Novartis Ag | 298.79 Bn | 291.10 Bn | 11.24 Bn |
| 5 | Astrazeneca | 255.57 Bn | 250.67 Bn | 12.86 Bn |
| 6 | Amgen | 233.87 Bn | 219.89 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 179.24 Bn | 176.06 Bn | 6.22 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 9 | Gsk | 104.53 Bn | 100.36 Bn | 8.24 Bn |
| 10 | Sanofi | 54.48 Bn | 47.10 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | -2,628.00 |
| Mar 29, 2026 | 1,734.00 |
| Dec 31, 2025 | -1,543.00 |
| Sep 28, 2025 | -11,390.00 |
| Jun 29, 2025 | 11,361.00 |
| Sep 29, 2024 | 1,848.00 |
| Jun 30, 2024 | -2,396.00 |
| Mar 31, 2024 | 14,323.00 |
| Jul 2, 2023 | -10,786.00 |
| Jul 3, 2022 | 599.00 |
| Oct 3, 2021 | -111.00 |
| Jul 4, 2021 | -244.00 |
| Sep 27, 2020 | -938.00 |
| Jun 28, 2020 | 249.00 |
| Sep 29, 2019 | 5,338.00 |
| Jun 30, 2019 | -173.00 |
| Mar 31, 2019 | 83,269.00 |
| Dec 31, 2018 | -83,115.00 |
| Sep 30, 2018 | -221.00 |
| Jul 1, 2018 | 164.00 |